Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 28 of Lantern Pharma Inc.'s SEC filings and found 6 warrant series, 1 ATM program, 1 shelf registration, 1 S-1 registration and 2 completed offerings on file for LTRN. The latest dilution event on file is an offering on Sep 30, 2026. Analysis updated Oct 13, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
BCLIBrainstorm Cell Therapeutics Inc.
PTNPalatin Technologies, Inc.
BLRXBioLineRX Ltd
CURXCuranex Pharmaceuticals Inc Common Stock
INABIN8bio, Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
CALCCalciMedica, Inc.
INTIInhibitor Therapeutics, Inc.
PHIOPhio Pharmaceuticals Corp.
TOVXTheriva Biologics, Inc.
CMMBChemomab Therapeutics Ltd. American Depositary Share
LEXXLexaria Bioscience Corp.
GTBPGT Biopharma, Inc.
MBRXMoleculin Biotech, Inc.
ICUSeaStar Medical Holding Corporation